SOUTH WINDSOR, CT -- Gerber Scientific, Inc. (NYSE: GRB) today reported net income of $2.2 million for the third quarter of fiscal 2007, or $0.10 per diluted share, on revenue of $137.1 million, compared with a net loss of $0.1 million, or essentially break even on a diluted share basis, on revenue of $124.6 million for the third quarter of fiscal 2006. Foreign currency translation had the effect of increasing revenue by approximately $6.1 million in the third quarter of fiscal 2007, as compared with the third quarter of fiscal 2006.

For the nine months ended January 31, 2007, the Company reported net income of $7.9 million, or $0.34 per diluted share, on revenue of $419.7 million, compared with a net loss of $1.3 million, or $0.06 per diluted share, on revenue of $387.3 million for the nine months ended January 31, 2006. Foreign currency translation had the effect of increasing revenue by approximately $12.0 million for the nine months ended January 31, 2007, as compared with the nine months ended January 31, 2006. The Company's net loss for the nine months ended January 31, 2006 included a $2.5 million charge associated with the early extinguishment of the Company's former credit facility and a $2.3 million tax charge associated with the reversal of a deferred tax asset in the United Kingdom. These items negatively impacted the prior year-to-date diluted earnings per share by $0.18.

Marc T. Giles, President and Chief Executive Officer, commented: "Results for the third quarter reflected our continued focus on growth with revenue up 10.0 percent versus a year ago. In addition to favorable currency translation, this growth was largely a result of our initiatives in new products and in China and other Asian markets. Though our gross margin percentage declined from the prior year primarily related to business unit and product mix, our earnings per share for the third quarter grew to $0.10 per diluted share driven by higher revenue and internal focus on cost control."

For additional information please see our Quarterly Report on Form 10-Q for the fiscal quarter ended January 31, 2007, which will be filed with the Securities and Exchange Commission.

Gerber Scientific, Inc. (http://www.gerberscientific.com) is a leading international supplier of sophisticated automated manufacturing systems for the sign making and specialty graphics, apparel and flexible materials and ophthalmic lens processing industries. Headquartered in South Windsor, Connecticut, the Company operates through four businesses: Gerber Scientific Products, Spandex Ltd., Gerber Technology and Gerber Coburn.